Search Results 61-70 of 17293 for hba1c

  1. Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in Type 1 and Type 2 Diabetes - Mayo Clinic

    HbA1c ³ 10.0%; For female subjects: positive pregnancy test at the time of enrollment or study; History of prior upper abdominal surgery such as adjustable ...

  2. A Research Study To See How A Weekly Insulin, Insulin Icodec, Helps In Reducing The Blood Sugar Compared To Daily Insulin Glargine, Both In Combination With Insulin Aspart, In Adults With Type 1 Diabetes - Mayo Clinic

    * HbA1c from 7.0-10.0 percentage (%) (53.0-85.8 millimoles per mole (mmol/mol)), both inclusive, at screening confirmed by central laboratory analysis.

  3. Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes - Mayo Clinic

    Diabetic subjects with HbA1c concentrations of ≤ 8%. Diabetic subjects will be either on diet and lifestyle therapy alone, or monotherapy with metformin or ...

  4. Study of Critical Outcomes in Pregnant Patients on Insulin Pump with Type 1 Diabetes - Mayo Clinic

    HbA1c ≥ 6.5% documented;; Random glucose ≥ 200 mg/dL with symptoms;; No data at diagnosis is available but the participant has a convincing history of ...

  5. Advanced Hybrid Closed Loop (AHCL) System In Type 1 Adult And Pediatric Subjects Utilizing Lyumjev® Insulin Lispro-aabc - Mayo Clinic

    Has a Glycosylated hemoglobin (HbA1c) less than 10% (as processed by Central Lab) at time of screening visit. Note: All HbA1c blood specimens will be sent ...

  6. Pioglitazone Versus Empagliflozin For Chronic Pancreatitis/Recurrent Acute Pancreatitis Associated Diabetes Mellitus - Mayo Clinic

    * HbA1c level 7-10% at screening visit. * Fasting plasma glucose <220 mg/dL at screening visit. * Not on any antihyperglycemic medication except Metformin

  7. Risk Prediction For Immune Checkpoint Inhibitor Associated Diabetes Mellitus - Mayo Clinic

    New onset of diabetes mellitus any time after initiating ICI therapy based on criteria: HbA1c >6.4 % or FPG ≥126mg/dl on two occasions or OGTT >199 on two ...

  8. The International Diabetes Closed Loop (iDCL) Trial: Protocol 1 - Mayo Clinic

    HbA1c level <10.5% at screening; For females, not currently known to be pregnant; Willingness not to add glucose-lowering agents (such as Pramlintide ...

  9. Blood sugar levels can fluctuate for many reasons - Mayo Clinic

    Hormonal changes. Physical or emotional stress triggers the release of hormones that can cause high blood sugar levels. Menstrual periods and menopause also ...

  10. Safety And Efficacy Of EndoBarrier In Subjects With Type 2 Diabetes Who Are Obese - Mayo Clinic

    HbA1c ≥ 7.5% and ≤ 10%; BMI ≥ 30 and ≤ 55. Exclusion Criteria: Diagnosis of type 1 diabetes mellitus or having any history of ketoacidosis; C-peptide < 1.0 ...